{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:35:21Z","timestamp":1789133721112,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005317","name":"Kermanshah University of Medical Sciences","doi-asserted-by":"publisher","award":["980308"],"award-info":[{"award-number":["980308"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["984494"],"award-info":[{"award-number":["984494"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.abb.2019.108218","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:24:12Z","timestamp":1575285852000},"page":"108218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The antidepressant drug; trazodone inhibits Tau amyloidogenesis: Prospects for prophylaxis and treatment of AD"],"prefix":"10.1016","volume":"679","author":[{"given":"Vali","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirous","family":"Ghobadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer's disease: the path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimer's Res. Ther."},{"issue":"6","key":"10.1016\/j.abb.2019.108218_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.abb.2019.108218_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/156720510793611600","article-title":"Tau aggregation is a therapeutic target for Alzheimer's disease","volume":"7","author":"Takashima","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"5825","key":"10.1016\/j.abb.2019.108218_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous Tau ameliorates amyloid \u00df-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.abb.2019.108218_bib5","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"39","key":"10.1016\/j.abb.2019.108218_bib6","doi-asserted-by":"crossref","first-page":"24290","DOI":"10.1016\/S0021-9258(19)51080-8","article-title":"Structural studies of Tau protein and Alzheimer paired helical filaments show no evidence for beta-structure","volume":"269","author":"Schweers","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","article-title":"Physical and chemical properties of purified Tau factor and the role of Tau in microtubule assembly","volume":"116","author":"Cleveland","year":"1977","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.abb.2019.108218_bib8","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1021\/ja067482k","article-title":"Amino acid bulkiness defines the local conformations and dynamics of natively unfolded \u03b1-synuclein and Tau","volume":"129","author":"Cho","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1110\/ps.4210102","article-title":"Natively unfolded proteins: a point where biology waits for physics","volume":"11","author":"Uversky","year":"2002","journal-title":"Protein Sci."},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib10","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1073\/pnas.1031522100","article-title":"Role of backbone solvation and electrostatics in generating preferred peptide backbone conformations: distributions of phi","volume":"100","author":"Avbelj","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.abb.2019.108218_bib11","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/ja01091a003","article-title":"The configuration of random polypeptide chains. II. Theory","volume":"87","author":"Brant","year":"1965","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.abb.2019.108218_bib12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0021-9258(18)96726-8","article-title":"Proteins in 6 M guanidine hydrochloride demonstration of random coil behavior","volume":"241","author":"Tanford","year":"1966","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.abb.2019.108218_bib13","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/bi800783d","article-title":"The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments","volume":"47","author":"Jeganathan","year":"2008","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.abb.2019.108218_bib14","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1073\/pnas.1418155112","article-title":"Regulation and aggregation of intrinsically disordered peptides","volume":"112","author":"Levine","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"33","key":"10.1016\/j.abb.2019.108218_bib15","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1073\/pnas.1001743107","article-title":"Charge interactions can dominate the dimensions of intrinsically disordered proteins","volume":"107","author":"M\u00fcller-Sp\u00e4th","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.abb.2019.108218_bib16","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1021\/cr400525m","article-title":"Classification of intrinsically disordered regions and proteins","volume":"114","author":"Van Der Lee","year":"2014","journal-title":"Chem. Rev."},{"issue":"43","key":"10.1016\/j.abb.2019.108218_bib17","first-page":"10626","article-title":"Structure and novel exons of the human","volume":"31","author":"Andreadis","year":"1992","journal-title":"Tau Gene, Biochem."},{"key":"10.1016\/j.abb.2019.108218_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0074-7696(01)10006-9","article-title":"Regulation of microtubule-associated proteins","author":"Cassimeris","year":"2001","journal-title":"Int. Rev. Cytol."},{"issue":"6","key":"10.1016\/j.abb.2019.108218_bib19","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","article-title":"Tau protein function in living cells","volume":"103","author":"Drubin","year":"1986","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0955-0674(00)00172-1","article-title":"Going new places using an old MAP: tau, microtubules and human neurodegenerative disease","volume":"13","author":"Garcia","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.abb.2019.108218_bib21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/j.1460-2075.1995.tb07116.x","article-title":"Somatodendritic localization and hyperphosphorylation of Tau protein in transgenic mice expressing the longest human brain Tau isoform","volume":"14","author":"G\u00f6tz","year":"1995","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib22","first-page":"309","article-title":"The phosphorylation of Tau: a critical stage in neurodevelopment and neurodegenerative processes","volume":"78","author":"Lovestone","year":"1997","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.abb.2019.108218_bib23","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative Tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Ann. Rev. Neurosci."},{"issue":"6480","key":"10.1016\/j.abb.2019.108218_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/369488a0","article-title":"Altered microtubule organization in small-calibre axons of mice lacking Tau protein","volume":"369","author":"Harada","year":"1994","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.abb.2019.108218_bib27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003495-198121060-00001","article-title":"Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety","volume":"21","author":"Brogden","year":"1981","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.abb.2019.108218_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4088\/JCP.10m06223blu","article-title":"The future of psychopharmacology of depression","volume":"71","author":"Chang","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.amjopharm.2011.02.003","article-title":"Potentially procholinergic effects of medications commonly used in older adults","volume":"9","author":"Rockwood","year":"2011","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib30","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/BF00172631","article-title":"Overview of USA controlled trials of trazodone in clinical depression","volume":"95","author":"Feighner","year":"1988","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.abb.2019.108218_bib31","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/brain\/awx074","article-title":"Repurposed drugs targeting eIF2\u03b1-P-mediated translational repression prevent neurodegeneration in mice","volume":"140","author":"Halliday","year":"2017","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib32","doi-asserted-by":"crossref","first-page":"734","DOI":"10.7326\/0003-4819-149-10-200811180-00008","article-title":"Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians","volume":"149","author":"Gartlehner","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr."},{"issue":"9","key":"10.1016\/j.abb.2019.108218_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.2042-7158.1982.tb04807.x","article-title":"Plasma concentrations of trazodone and 1\u2010(3\u2010chlorophenyl) piperazine in man after a single oral dose of trazodone","volume":"34","author":"Caccia","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007691-200208000-00016","article-title":"Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients","volume":"24","author":"Mihara","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0278-5846(96)00140-6","article-title":"Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone","volume":"21","author":"Otani","year":"1997","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00004714-198908000-00009","article-title":"Plasma trazodone concentrations and clinical response in elderly depressed patients: a preliminary study","volume":"9","author":"Monteleone","year":"1989","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/clpt.1987.132","article-title":"Trazodone kinetics: effect of age, gender, and obesity","volume":"42","author":"Greenblatt","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6600","key":"10.1016\/j.abb.2019.108218_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/383550a0","article-title":"Assembly of microtubule-associated protein Tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans","volume":"383","author":"Goedert","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib40","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1046\/j.1471-4159.2000.0741749.x","article-title":"Differential assembly of human Tau isoforms in the presence of arachidonic acid","volume":"74","author":"King","year":"2000","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1091\/mbc.12.1.171","article-title":"Competition for microtubule-binding with dual expression of Tau missense and splice isoforms","volume":"12","author":"Lu","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.abb.2019.108218_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fneur.2018.00070","article-title":"Tau filaments and the development of positron emission tomography tracers","volume":"9","author":"Goedert","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.abb.2019.108218_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and Tau hypothesis in Alzheimer's disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.abb.2019.108218_bib44","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ijbiomac.2018.08.175","article-title":"Effective suppression of the modified PHF6 peptide\/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: another evidence for the pigment as preventive\/therapeutic \u201cfunctional food\u201d","volume":"120","author":"Bijari","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/brain\/awx342","article-title":"Potentiating tangle formation reduces acute toxicity of soluble Tau species in the rat","volume":"141","author":"d'Orange","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molbrainres.2005.04.012","article-title":"Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation","volume":"138","author":"Rankin","year":"2005","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymeth.2004.03.012","article-title":"Techniques to study amyloid fibril formation in vitro","volume":"34","author":"Nilsson","year":"2004","journal-title":"Methods"},{"issue":"20","key":"10.1016\/j.abb.2019.108218_bib48","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","article-title":"The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds","volume":"276","author":"Hudson","year":"2009","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib49","doi-asserted-by":"crossref","first-page":"160696","DOI":"10.1098\/rsos.160696","article-title":"Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation","volume":"4","author":"Xue","year":"2017","journal-title":"R. Soc. Open Sci."},{"issue":"3","key":"10.1016\/j.abb.2019.108218_bib50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbadis.2004.11.024","article-title":"Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease","volume":"1740","author":"Santa-Mar\u00eda","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib51","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","article-title":"Assembly of \u03c4 protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming \u03b2 structure","volume":"97","author":"Von Bergen","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.abb.2019.108218_bib52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbagen.2004.10.013","article-title":"Flavonoid\u2013serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy","volume":"1721","author":"Dufour","year":"2005","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.abb.2019.108218_bib53","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","year":"2013"},{"issue":"21","key":"10.1016\/j.abb.2019.108218_bib54","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/bi00745a020","article-title":"Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules","volume":"12","author":"Lakowicz","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2019.108218_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.saa.2016.08.005","article-title":"Fluorescence spectroscopic and molecular docking studies of the binding interaction between the new anaplastic lymphoma kinase inhibitor crizotinib and bovine serum albumin","volume":"171","author":"Abdelhameed","year":"2017","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib56","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-9936(98)00112-5","article-title":"Applications of circular dichroism in protein and peptide analysis","volume":"18","author":"Greenfield","year":"1999","journal-title":"Trac. Trends Anal. Chem."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpba.2005.11.037","article-title":"Study of the interaction of an anticancer drug with human and bovine serum albumin: spectroscopic approach","volume":"41","author":"Kandagal","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.abb.2019.108218_bib58","series-title":"X-Ray Diffraction in Biology: How Can We See DNA and Proteins in Three Dimensions?","author":"Mayer","year":"2017"},{"issue":"23","key":"10.1016\/j.abb.2019.108218_bib59","doi-asserted-by":"crossref","first-page":"17042","DOI":"10.1074\/jbc.M113.472746","article-title":"Rapid accumulation of endogenous Tau oligomers in a rat model of traumatic brain injury possible link between traumatic brain injury and sporadic Tauopathies","volume":"288","author":"Hawkins","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-121765","article-title":"Molecular mechanism of Tau aggregation induced by anionic and cationic dyes","volume":"35","author":"Le\u00f3n","year":"2013","journal-title":"J. Alzheimer's Dis."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.snb.2005.12.014","article-title":"Study of interactions of flavonoids with DNA using acridine orange as a fluorescence probe","volume":"119","author":"Bi","year":"2006","journal-title":"Sens. Actuators B Chem."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib62","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1073\/pnas.76.4.1962","article-title":"Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter","volume":"76","author":"Parks","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-2952(91)90021-V","article-title":"Drug binding to human erythrocytes in the process of ionic drug-induced hemolysis: flow microcalorimetric approaches","volume":"41","author":"Aki","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2019.108218_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2015.02.001","article-title":"An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience","volume":"73","author":"Kaja","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"9","key":"10.1016\/j.abb.2019.108218_bib65","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of \u03b1-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jmb.2005.08.046","article-title":"Characterization of oligomeric intermediates in \u03b1-synuclein fibrillation: FRET studies of Y125W\/Y133F\/Y136F \u03b1-synuclein","volume":"353","author":"Kaylor","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2019.108218_bib67","first-page":"306","volume":"vol. 7","author":"Lindahl","year":"2001"},{"issue":"8","key":"10.1016\/j.abb.2019.108218_bib68","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"14","key":"10.1016\/j.abb.2019.108218_bib69","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1103\/PhysRevLett.45.1196","article-title":"Crystal structure and pair potentials: a molecular-dynamics study","volume":"45","author":"Parrinello","year":"1980","journal-title":"Phys. Rev. Lett."},{"issue":"12","key":"10.1016\/j.abb.2019.108218_bib70","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.abb.2019.108218_bib71","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5 log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"23","key":"10.1016\/j.abb.2019.108218_bib72","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1093\/bioinformatics\/btr550","article-title":"MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories","volume":"27","author":"Schmidtke","year":"2011","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib73","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.abb.2019.108218_bib74","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/37.8.2666510","article-title":"Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation","volume":"37","author":"Klunk","year":"1989","journal-title":"J. Histochem. Cytochem."},{"issue":"2","key":"10.1016\/j.abb.2019.108218_bib75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1110\/ps.03183404","article-title":"Formation of amyloid fibrils from fully reduced hen egg white lysozyme","volume":"13","author":"Cao","year":"2004","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib76","first-page":"771","article-title":"Why Congo red binding is specific for amyloid proteins-model studies and a computer analysis approach","volume":"7","author":"Roterman","year":"2001","journal-title":"Med. Sci. Monit."},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib77","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1529\/biophysj.106.098608","article-title":"A three-stage kinetic model of amyloid fibrillation","volume":"92","author":"Lee","year":"2007","journal-title":"Biophys. J."},{"issue":"1\u20133","key":"10.1016\/j.abb.2019.108218_bib78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhazmat.2009.10.107","article-title":"Interaction of anthraquinone dyes with lysozyme: evidences from spectroscopic and docking studies","volume":"175","author":"Paramaguru","year":"2010","journal-title":"J. Hazard Mater."},{"issue":"11","key":"10.1016\/j.abb.2019.108218_bib79","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1021\/bi00514a017","article-title":"Thermodynamics of protein association reactions: forces contributing to stability","volume":"20","author":"Ross","year":"1981","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib80","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s11095-010-0297-1","article-title":"Strategies for the assessment of protein aggregates in pharmaceutical biotech product development","volume":"28","author":"Den Engelsman","year":"2011","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.abb.2019.108218_bib81","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1529\/biophysj.105.070136","article-title":"Structure of core domain of fibril-forming PHF\/Tau fragments","volume":"90","author":"Inouye","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.abb.2019.108218_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-61779-551-0_9","article-title":"X-ray fibre diffraction studies of amyloid fibrils","author":"Morris","year":"2012","journal-title":"Amyloid Proteins"},{"key":"10.1016\/j.abb.2019.108218_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.saa.2015.10.022","article-title":"Methylglyoxal-induced modification causes aggregation of myoglobin","volume":"155","author":"Banerjee","year":"2016","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"6","key":"10.1016\/j.abb.2019.108218_bib84","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1074\/jbc.M109.035691","article-title":"Quantitative characterization of heparin binding to Tau protein implication for inducer-mediated Tau filament formation","volume":"285","author":"Zhu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3\u20134","key":"10.1016\/j.abb.2019.108218_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2012.10.129","article-title":"Soluble oligomers and fibrillar species of amyloid \u03b2-peptide differentially affect cognitive functions and hippocampal inflammatory response","volume":"429","author":"He","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib86","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2007.11.096","article-title":"An scFv intrabody against the nonamyloid component of \u03b1-synuclein reduces intracellular aggregation and toxicity","volume":"377","author":"Lynch","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.abb.2019.108218_bib87","doi-asserted-by":"crossref","first-page":"687","DOI":"10.15252\/emmm.201607054","article-title":"Antibodies inhibit transmission and aggregation of C9orf72 poly\u2010GA dipeptide repeat proteins","volume":"9","author":"Zhou","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.abb.2019.108218_bib88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mbs.2015.12.004","article-title":"Determination of critical nucleation number for a single nucleation amyloid-\u03b2 aggregation model","volume":"273","author":"Ghosh","year":"2016","journal-title":"Math. Biosci."},{"issue":"5","key":"10.1016\/j.abb.2019.108218_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063822","article-title":"Metabolic states following accumulation of intracellular aggregates: implications for neurodegenerative diseases","volume":"8","author":"Vazquez","year":"2013","journal-title":"PLoS One"},{"issue":"5619","key":"10.1016\/j.abb.2019.108218_bib90","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of Tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1073\/pnas.94.1.298","article-title":"Abnormal phosphorylation of Tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal Tau","volume":"94","author":"Alonso","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.abb.2019.108218_bib92","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1073\/pnas.91.12.5562","article-title":"Role of abnormally phosphorylated Tau in the breakdown of microtubules in Alzheimer disease","volume":"91","author":"Alonso","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib93","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","article-title":"Levels of normal and abnormally phosphorylated Tau in different cellular and regional compartments of Alzheimer disease and control brains","volume":"351","author":"Khatoon","year":"1994","journal-title":"FEBS Lett."},{"issue":"28","key":"10.1016\/j.abb.2019.108218_bib94","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1073\/pnas.0401911101","article-title":"Template-assisted filament growth by parallel stacking of Tau","volume":"101","author":"Margittai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib95","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1517\/13543784.2015.1075002","article-title":"Early investigational drugs targeting Tau protein for the treatment of Alzheimer's disease","volume":"24","author":"Anand","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib96","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1567205011666141107150331","article-title":"Structure and mechanism of action of Tau aggregation inhibitors","volume":"11","author":"Cisek","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib97","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","article-title":"Tau-aggregation inhibitor therapy for Alzheimer's disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2019.108218_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009178","article-title":"Pharmacotherapies for sleep disturbances in Alzheimer's disease","volume":"6","author":"Modabbernia","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib99","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881117742101","article-title":"Evaluating the dose-dependent mechanism of action of trazodone by estimation of occupancies for different brain neurotransmitter targets","volume":"32","author":"Settimo","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.abb.2019.108218_bib100","first-page":"1","article-title":"Long-term trazodone use and cognition: a potential therapeutic role for slow-wave sleep enhancers","author":"La","year":"2019","journal-title":"J. Alzheimer's Dis."},{"issue":"10","key":"10.1016\/j.abb.2019.108218_bib101","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/0269881110364269","article-title":"Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington\u2019s-like symptoms: a comparative study","volume":"25","author":"Kumar","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.abb.2019.108218_bib102","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3109\/07420528.2015.1077855","article-title":"Circadian rhythm in Alzheimer disease after trazodone use","volume":"32","author":"Grippe","year":"2015","journal-title":"Chronobiol. Int."},{"issue":"4","key":"10.1016\/j.abb.2019.108218_bib103","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02244985","article-title":"Binding of antidepressants to human brain receptors: focus on newer generation compounds","volume":"114","author":"Cusack","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.abb.2019.108218_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2016.09.004","article-title":"Appraisal of role of the polyanionic inducer length on amyloid formation by 412-residue 1N4R Tau protein: a comparative study","volume":"609","author":"Jangholi","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.abb.2019.108218_bib105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","article-title":"A walk through Tau therapeutic strategies","volume":"7","author":"Jadhav","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.1016\/j.abb.2019.108218_bib106","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986119307088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986119307088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:11:44Z","timestamp":1757743904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986119307088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":106,"alternative-id":["S0003986119307088"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2019.108218","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antidepressant drug; trazodone inhibits Tau amyloidogenesis: Prospects for prophylaxis and treatment of AD","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2019.108218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108218"}}